| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Chloroxine (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Methylbenzethonium |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Merbromin |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Bismuth violet |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| borsyremiddel til topikal anvendelse |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Chlorothymol |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Methylbenzethonium chloride |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| medicinsk zinkperoxid |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Iodine solution |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Halquinol |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Mercuric iodide |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Nitromersol |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Triclobisonium chloride |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| medicinsk iod |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Yellow mercuric oxide yellow |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Ammoniated mercury |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Aminoacridine (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Benzoyl peroxide (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Erythromycin (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Clindamycin (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Mafenide (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Oxychlorosene (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Benzethonium (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Silver nitrate (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Benzalkonium (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| antiinfektiøst middel til huden |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Product containing cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| cetylpyridiniumchlorid 0,066 % sugetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| cetylpyridiniumchlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| natriumperborat 68,6 % mundskyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| sølvsulfadiazin 10 mg/g creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Povidone iodine (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Triclosan (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Hexachlorophene (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Ichthammol (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Domiphen (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Mupirocin (substance) |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Product containing sodium perborate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Mercury ammonium chloride |
Is a |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Neomycin sulfate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Neomycin sulfate 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| neomycinsulfat 0,5 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Neomycin sulfate 5 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| neomycin 0,5 % + hydrocortison 1,5 % øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| neomycin + hydrocortison 0,5 %/1,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Product containing precisely tetracycline hydrochloride 2.2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Neomycin 0.5% cream BPC |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| kombinationspræparater med neomycin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Product containing hydrocortisone and neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Product containing precisely framycetin sulfate 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Product containing neomycin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| neomycin til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| tetracyclin til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| polymyxin B-sulfat + trimethoprim øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| polymyxin B-sulfat + bacitracinzink øjensalve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| polymyxin B-sulfat + trimethoprim øjensalve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Neomycin 5 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Product containing framycetin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Product containing polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Product containing neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| antibiotikum til huden |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Framycetin sulfate [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Neomycin sulfate [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Polymyxin B sulf [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Framycetin sulfate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Neomycin sulfate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Polymyxin B sulf [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| polymyxin B-øjensalve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| øjendråber indeholdende polymyxin B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Framycetin sulfate [ear] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Neomycin sulfate [ear] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Neomycin ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Neomycin ear ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Neomycin 0.5% ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Hydrocortisone/neomycin cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Framycetin sulfate [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Neomycin sulfate [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Polymyxin B sulfate [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Neomycin sulfate 25 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| polymyxin B-sulfat + bacitracinzink 10.000 enheder/500 enheder øjensalve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| tetracyclinhydrochlorid 1 % wt/vol suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| tetracyclinhydrochlorid 1 % salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| polymyxin B-sulfat 100 % pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| bacitracinzink 400 enheder + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| bacitracinzink 500 enheder + polymyxin B-sulfat 10.000 enheder salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| dexamethason 0,1 % wt/vol + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| dexamethason 0,1 % wt/vol + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| dexamethason 1 mg + neomycinsulfat 3,5 mg salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| Dexamethasone sodium phospha + neomycin sulfate 0ns/0ns solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| gramicidin 0,025 mg + neomycinsulfat 1,75 mg + polymyxin B-sulfat 10.000 enheder opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| hydrocortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| hydrocortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/10.000 opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
| hydrocortison 10 mg + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinfektiøst middel til huden |
Inferred relationship |
Some |
|
FHIR